Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids.
<h4>Introduction</h4>Despite evidence of possible patient harm and substantial costs, medication overuse is persistent. Patient reaction is one potential barrier to deprescribing, but little research has assessed this in specific instances of medication discontinuation. We sought to unde...
Main Authors: | Toral J Parikh, Krysttel C Stryczek, Chris Gillespie, George G Sayre, Laura Feemster, Edmunds Udris, Barbara Majerczyk, Seppo T Rinne, Renda Soylemez Wiener, David H Au, Christian D Helfrich |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0238511 |
Similar Items
-
Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids
by: Toral J. Parikh, et al.
Published: (2020-01-01) -
Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
by: Wuraola Akande-Sholabi, et al.
Published: (2023-01-01) -
Deprescribing no idoso
by: Ivone Dos Santos Martins
Published: (2013-01-01) -
Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis
by: Elliot B. Tapper, et al.
Published: (2022-06-01) -
Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
by: Katherine Le Bosquet, et al.
Published: (2019-09-01)